Ministers' media centre

Internationally renowned Commonwealth Fund has ranked Australia’s health system as the top performing country in 2024.

Residents in northern Brisbane and Moreton Bay will soon have free, walk-in mental health support and care with the opening of the Medicare Mental Health Centres in Caboolture, Redcliffe, Strathpine and Brisbane’s inner north.

Read the transcript of Minister Butler's interview with Matthew Pantelis on aged care; bulk billing investments; taking pressure off hospitals; GP workforce; proton therapy.

A new headspace service will open in Manjimup next year to provide mental health support to young people in the community and surrounding region.

South Australia’s strong enforcement has seen thousands of unlawful vapes taken off the shelves and out of the hands of young Australians.

Read the transcript of Minister Butler's interview with David Bevan on aged care reforms; taking pressure off hospitals; vaping enforcement.

Read the transcript of Minister Butler's press conference in Adelaide on vaping enforcement; taking pressure off hospitals; retirement villages; women's health; IV fluids; RSV vaccine and monoclonal antibodies.

Read the transcript of Assistant Minister McBride's interview with Paul Cook on the new headspace centre in Manjimup

Curtin University will lead a national study into the mental health and wellbeing of children aged 4 to 17, with support from an $8.1 million investment from the Australian Government.

The Australian Government has released the final report of the Health Technology Assessment (HTA) Review.

Australia continues to ramp up the fight against illicit vapes, with more than 5.2 million illicit vapes and vaping products seized so far this year. Of these, more than 2 million vapes have been seized since the commencement of the new vaping laws on 1 July 2024.

The Australian Government is calling for feedback on the draft National Suicide Prevention Strategy.

Australians with Fabry disease, a rare genetic condition, and people with kidney cancer now have access to cheaper medicines under the Pharmaceutical Benefits Scheme (PBS).

People across North Queensland will soon have free, walk-in mental health support and care with the opening of the Medicare Mental Health Centre in Mackay.

The Australian Government is investing $34.5 million in research funding to trial new treatments and therapies aiming to harness the power of stem cells to improve patient outcomes.

The Australian Government is delivering a further seven Medicare Urgent Care Clinics (Medicare UCCs) to give more Victorians access to high quality and free walk-in health care.

Read the transcript from Minister Butler's interview with Rafael Epstein which covered Medicare Urgent Care Clinics in Victoria, dental covered under Medicare, and illegal tobacco and vapes.

Read the transcript from Minister Butler's interview on 3AW Mornings which covered more Victorian Medicare Urgent Care Clinics, dental covered under Medicare, and illegal tobacco and vapes.

Read the transcript from Minister Butler's joint press conference with Mary Doyle MP and Dr Todd Cameron, which covered Victorian Medicare Urgent Care Clinics, covering dental services through Medicare, the private hospital sector review, and Victorian hospital funding.

The Australian Government is funding a promising treatment that could effectively put rheumatoid arthritis into remission and eliminate the need for lifelong immunotherapy.

Thanks to the Government Australians have saved over half a billion dollars ($525 million) on the cost of their medicines.

Read the transcript of Minister Butler's press conference which covered cheaper medicines, 60-day prescriptions, RSV and long stay older patients.

Australians diagnosed with a type of metastatic breast cancer will now have access to a life prolonging treatment under the Pharmaceutical Benefits Scheme (PBS) from 1 September 2024.

Read the transcript of Minister Butler's press conference on PBS listing for breast cancer medicine; 22 million additional IV fluid bags.

Due to unexpected increases in demand and manufacturing capacity constraints, there has been global supply limitations for IV fluids.